Paul J Lytle's Net Worth
$1.69 Million
Who is Paul J Lytle?
Paul J Lytle has an estimated net worth of $1.69 Million. This is based on reported shares across multiple companies, which include PEREGRINE PHARMACEUTICALS INC, and Mosaic ImmunoEngineering Inc..
SEC CIK
Paul J Lytle's CIK is 0001244110
Past Insider Trading and Trends
2012 was Paul J Lytle's most active year for acquiring shares with 5 total transactions. Paul J Lytle's most active month to acquire stocks was the month of September. 2011 was Paul J Lytle's most active year for disposing of shares, totalling 3 transactions. Paul J Lytle's most active month to dispose stocks was the month of March. 2020 saw Paul J Lytle paying a total of $264,541.20 for 80,164 shares, this is the most they've acquired in one year. In 2007 Paul J Lytle cashed out on 30,000 shares for a total of $18,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PEREGRINE PHARMACEUTICALS INC (CDMO) Snapshot price: $6.22
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.50% | 37.39K |
$0.27 | $10,139.90 | 184.04K |
Apr 28
| |||
Form 4
| +29.93% | 33.78K |
$0.29 | $9,675.45 | 146.65K |
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
| +5.77% | 6.16K |
$0.95 | $5,850.10 | 112.87K |
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
| +5.14% | 5.22K |
$1.11 | $5,790.87 | 106.71K |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
| +13.39% | 11.99K |
$0.71 | $8,511.48 | 101.49K |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 27
| |||
Form 4
| +30.44% | 20.89K |
$0.39 | $8,145.15 | 89.5K |
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
| +22.27% | 12.5K |
$0.40 | $4,999.20 | 68.62K |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
| +10.04% | 5.12K |
$0.89 | $4,558.58 | 56.12K |
Oct 31
| |||
Form 4
| -17.65% | -9.00K |
—
|
—
| 42K |
Jun 30
| |||
Form 4
| -16.73% | -12.05K |
$1.28 | $7,612.16 | 60K |
Apr 29 - May 2
| |||
Form 4
| +14.27% | 9K |
—
|
—
| 72.05K |
Feb 10
| |||
Form 4
| -12.49% | -9.00K |
—
|
—
| 63.05K |
Dec 31
| |||
Form 4
| +10.23% | 6.68K |
$1.34 | $8,956.56 | 72.05K |
Sep 24
| |||
Form 4
| +8.28% | 5K |
$1.33 | $6,650.00 | 65.37K |
Sep 23
| |||
Form 4
| +292.84% | 45K |
—
|
—
| 60.37K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
| +27.74% | 16.68K |
$0.59 | $9,824.13 | 76.83K |
Aug 20
| |||
Form 4
| +99.51% | 30K |
$0.60 | $18,000.00 | 60.15K |
Jun 11
| |||
Form 4
| +66.66% | 12.06K |
—
|
—
| 30.15K |
Nov 17
| |||
Form 4
| +199.98% | 12.06K |
—
|
—
| 18.09K |
Oct 24
| |||
Form 4
| +100.00% | 3.02K |
—
|
—
| 6.03K |
Jun 7
| |||
Form 4
|
∞
| 3.02K |
—
|
—
| 3.02K |
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 21
| |||
| No matching records found | |||||||||
Mosaic ImmunoEngineering Inc. (CPMV) No price found
EVP, Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.64M |
—
|
—
| 1.64M |
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACTUATE THERAPEUTICS, INC. (ACTU) No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||